anyone knows another 100 million revenue biotech stock

except XOMA?

$100 million from three approaches: BCE tech, contacts and fees. Pipeline XOMA052 PhII diabete & cardiovascular disease and this evening\'s news add another indicator: cancer.

http://finance.yahoo.com/news/XOMA-052-Shows-Potent-In-pz-1856791017.html?x=0&.v=1